For the quarter ending 2026-03-31, WVE made $38,246K in revenue. -$26,091K in net income. Net profit margin of -68.22%.
| Income Statement | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
| Revenue | 38,246 | 17,245 | 7,608 | 8,699 |
| Research and development | 47,440 | 52,814 | 45,874 | 43,469 |
| General and administrative | 22,104 | 20,898 | 18,087 | 17,989 |
| Total operating expenses | 69,544 | 73,712 | 63,961 | 61,458 |
| Loss from operations | -31,298 | -56,467 | -56,353 | -52,759 |
| Dividend income and interest income, net | - | 3,054 | - | - |
| Interest income | 5,291 | - | 2,177 | 2,372 |
| Other income (expense), net | -80 | 234 | 324 | -82 |
| Total other income, net | 5,211 | 3,288 | 2,501 | 2,290 |
| Loss before income taxes | -26,087 | -53,179 | -53,852 | -50,469 |
| Income tax benefit | 0 | 0 | 0 | 0 |
| Net loss | -26,087 | -53,179 | -53,852 | -50,469 |
| Foreign currency translation loss (gain) | -4 | -60 | -29 | 43 |
| Comprehensive loss | -26,091 | -53,239 | -53,881 | -50,426 |
| Basic EPS | -0.13 | -0.295 | -0.32 | -0.31 |
| Diluted EPS | -0.13 | -0.295 | -0.32 | -0.31 |
| Basic Average Shares | 200,167,869 | 180,345,306 | 167,739,208 | 163,987,640 |
| Diluted Average Shares | 200,167,869 | 180,345,306 | 167,739,208 | 163,987,640 |
Wave Life Sciences Ltd. (WVE)
Wave Life Sciences Ltd. (WVE)